-transparent.png){kind=logo}
Leukocyte migration inhibition factor (LMIF) activity expressed as a migration index was studied in sera of 13 chronic lymphatic leukemia (CLL) patients and 14 healthy subjects. LMIF activity was present in 92.8% of CLL patients and 14% of controls. The LMIF activity of lymphocyte culture supernatants in the same patients and 7 controls was also studied. A LMIF-like activity was found both, in the sera and phytohemagglutinin (PHA) unstimulated cell supernatants in 9 of 13 patients (69.2%). These results demonstrate the ability of malignant B cells to release LMIF or LMIF-like factors spontaneously.
Related Publications
S M Crivii, and
M Crişan, and
M Crişan
January 1981,
Archivum immunologiae et therapiae experimentalis,
S M Crivii, and
M Crişan, and
M Crişan
November 1979,
Journal of the National Cancer Institute,
S M Crivii, and
M Crişan, and
M Crişan
September 1976,
Journal of immunology (Baltimore, Md. : 1950),
S M Crivii, and
M Crişan, and
M Crişan
December 1976,
Clinical and experimental immunology,
S M Crivii, and
M Crişan, and
M Crişan
August 1975,
Proceedings of the National Academy of Sciences of the United States of America,
S M Crivii, and
M Crişan, and
M Crişan
March 1976,
The American review of respiratory disease,
S M Crivii, and
M Crişan, and
M Crişan
June 1969,
Journal of bacteriology,
S M Crivii, and
M Crişan, and
M Crişan
February 1993,
Schweizerische medizinische Wochenschrift,
S M Crivii, and
M Crişan, and
M Crişan
January 1964,
Cancer,
S M Crivii, and
M Crişan, and
M Crişan
February 1982,
Tumori,
